Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$439,111
-$28,492 QoQ
Shares Held
1,745
-18.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#3,288
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CFO4Life Group, LLC holds $7,374,448 across 8 Drug Manufacturers - General names. ABBV ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,539 | $2,676,589 | |
| 2 | LLY |
ELI LILLY & Co
|
1,589 | $1,905,894 | |
| 3 | NVS |
Novartis AG
|
4,916 | $770,435 | |
| 4 | AMGN |
Amgen Inc
|
1,340 | $485,240 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
1,745 | $439,111 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,156 | $398,729 | |
| 7 | PFE |
Pfizer Inc
|
15,403 | $370,904 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,549 | $327,546 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $439,111 | 1,745 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $467,603 | 2,150 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $764,299 | 3,345 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $782,142 | 3,378 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $610,875 | 3,291 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $693,720 | 3,311 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $568,106 | 3,197 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $589,477 | 2,985 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $494,835 | 2,885 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $529,546 | 2,908 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $489,705 | 3,160 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $574,030 | 3,851 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $506,315 | 3,758 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $671,585 | 4,214 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $713,508 | 4,415 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $527,713 | 3,932 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $722,915 | 4,720 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $739,059 | 4,559 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $593,187 | 4,381 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $303,869 | 2,817 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $317,306 | 2,817 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $344,572 | 3,184 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $352,202 | 3,287 | Shares | Sole | 2021-01-12 | |
| No filing history on record for this holder in this stock. | ||||||